Remibrutinib for treating chronic spontaneous urticaria inadequately controlled by H1-antihistamines [ID6356] Technology appraisal guidance Repotrectinib for treating NTRK fusion-positive advanced ...
1 Division of Dermato-Venerology, Department of Medicine, Solna, and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden 2 Department of Dermatology, Karolinska University Hospital ...
Phenotypic characterization and adhesive properties of vaginal Candida spp. strains provided by the CHU Farhat Hached (Sousse, Tunisia).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback